ClinicalTrials.Veeva

Menu

Prediction of Lymph Node Invasion for Prostate Adenocarcinoma (PRED-NCHIR)

R

Regional University Hospital Center (CHRU)

Status

Unknown

Conditions

Adenocarcinoma of the Prostate

Study type

Observational

Funder types

Other

Identifiers

NCT04909957
29BRC20.0290

Details and patient eligibility

About

Despite lymph node involvement (LNI) being one of the main prognostic factors in patients with prostate cancer (PCa), pelvic lymph node irradiation remains debated, possibly due to an insufficient selection of patients. Significant advances in LNI risk modelling have been achieved with the addition of visual interpretation of magnetic resonance imaging (MRI) data, but it is likely that quantitative analysis could further improve prediction models. In this study, the investigators aimed to develop and internally validate a novel LNI risk prediction model based on radiomic features extracted from pre-operative multimodal MRI.

Enrollment

400 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologically proven adenocarcinoma of the prostate treated by prostatectomy with extensive lymph node dissection
  • Available pre-operative +/- PET choline

Exclusion criteria

  • Unanalyzable pre-operative MRI

Trial design

400 participants in 2 patient groups

Absence of invaded lymph node after extensive lymph node dissection
Description:
Absence of invaded lymph node after extensive lymph node dissection
Presence of invaded lymph node after extensive lymph node dissection
Description:
Presence of invaded lymph node after extensive lymph node dissection

Trial contacts and locations

1

Loading...

Central trial contact

Ulrike Ulrike Schick

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems